Mesoblast Limited

NASDAQ: MESO · Real-Time Price · USD
15.95
-0.30 (-1.85%)
At close: Aug 18, 2025, 10:45 AM

Mesoblast Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
5.9M 7.5M 10.21M 7.46M
Cost of Revenue
41.07M 54.92M 63.57M 85.73M
Gross Profit
-35.17M -47.42M -53.36M -78.28M
Operating Income
-84.15M -69.29M -80.57M -109.1M
Interest Income
1.82M 831K 3K 22K
Pretax Income
-88.15M -82.1M -91.59M -99.63M
Net Income
-87.96M -81.89M -91.35M -98.81M
Selling & General & Admin
23.63M 53.11M 57.97M 63.59M
Research & Development
25.35M 27.19M 32.81M 53.01M
Other Expenses
n/a n/a 30.76M 32.65M
Operating Expenses
48.98M 76.79M 90.78M 115.06M
Interest Expense
20.66M 19.44M 17.29M 10.71M
Selling & Marketing Expenses
n/a 27.73M 30.76M 32.72M
Cost & Expenses
90.05M 76.79M 90.78M 115.06M
Income Tax Expense
191K -212K -239K -819K
Shares Outstanding (Basic)
98.67M 83.77M 68.27M 60.51M
Shares Outstanding (Diluted)
98.67M 83.93M 68.29M 60.51M
EPS (Basic)
-0.89 -0.98 -1.3 -1.6
EPS (Diluted)
-0.89 -0.98 -1.3 -1.6
EBITDA
-56.08M -58.55M -76.57M -107.6M
EBIT
-57.97M -62.66M -74.3M -88.92M
Depreciation & Amortization
1.9M 4.11M 4.38M 4.26M